1상모집 중단 (진행 중)

Safety and Preliminary Efficacy of BNT314 in Cancer Patients With Malignant Solid Tumors

연구 개요

The purpose of this first-in-human study is to find out if BNT314 is safe when it is used alone in patients with different types of cancer. This is a dose escalation study in which patients will be assigned to multiple dose levels (DLs) of BNT314 given alone. By escalating the dose with a small group of patients, the Maximum Tolerated Dose which is the highest dose with acceptable safety and manageable side effects, or the maximum administered dose will be investigated.

스폰서
리드: 바이오엔테크
적응증
Advanced Malignant Solid Tumor
중재
BNT314
목표 등록
41
시작일
2023-11-30
완료(예정)
2028-03-01

BioPulse가 제공하는 정보는 공개된 자료를 요약·정리한 것으로, 투자 조언이나 의료 조언이 아닙니다. 임상 데이터·규제 일정·공시 내용은 반드시 원문을 직접 확인하시기 바랍니다.